MedTrace Logo

Project HOPES: Healthy Options for Pain and Ending Smoking. A Program for Cancer Survivors.

NCT06029907 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2025-09-04

No results posted yet for this study

Summary

The proposed pilot study will develop and test feasibility, acceptability, and signal for efficacy of a smoking cessation and pain management intervention for 20 cancer survivors.

Conditions

  • Smoking Cessation
  • Pain

Interventions

OTHER

Smoking cessation and pain management intervention

Patients will receive a behavioral smoking cessation and pain management intervention

DRUG

Varenicline

Patients will receive varenicline prescribed by their oncologist

Sponsors & Collaborators

Principal Investigators

  • Kathryn I Pollak, PhD · Duke University

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-15
Primary Completion
2025-08-29
Completion
2025-08-29
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06029907 on ClinicalTrials.gov